Shilpa Medicare Ltd. NSE: SHILPAMED | BSE: 530549

Mid-range Performer

Download real time

824.85 6.40 (0.78%)

48.62% Gain from 52W Low

364.9K

NSE+BSE Volume

High volume today

NSE 23 Sep, 2025 3:31 PM (IST)

Drug Approval

Shilpa Medicare gets EMA nod for Rivaroxaban, targeting the European market valued at $2.5 billion See details

Shilpa Medicare Ltd. Earnings/Conference Calls

Shilpa Medicare Ltd. earnings concalls and investor presentations

Load latest

Is Shilpa Medicare Ltd. worth buying?

248 Votes:

Buy 79.03%

Sell 11.69%

Hold 9.27%